biguanides has been researched along with Diabetic Angiopathies in 23 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two diabetic patients who developed lactic acidosis following the use of Buformin." | 7.67 | [Lactic acidosis in diabetic patients associated with buformin]. ( Díaz, RA; Hernández, G; Huidobro, F; Jimenez, R; Pérez, H; Torres, H; Videla, C, 1989) |
| "Our results conclude that 10% decrease in body mass index (BMI) among overweight patients, smoking cessation, initiation to undertake a preventive treatment with low-dose aspirin, initiation to undertake or intensify blood pressure control, initiation to undertake or intensify lipidic control, and shift to biguanides among overweight patients are factors associated with significant benefits (avoided costs) which compensate for the increase in treatment costs." | 3.73 | [Assessment of the budgetary impact of treatment guidelines in type II diabetes mellitus in France]. ( Crainich, D; Lebrun, T; Marissal, JP; Sailly, JC, 2005) |
| "We report two diabetic patients who developed lactic acidosis following the use of Buformin." | 3.67 | [Lactic acidosis in diabetic patients associated with buformin]. ( Díaz, RA; Hernández, G; Huidobro, F; Jimenez, R; Pérez, H; Torres, H; Videla, C, 1989) |
| "impaired glucose tolerance (IGT) and NIDDM, conveys a great risk of macrovascular disease." | 2.39 | Oral antidiabetic drugs: an overview. ( Melander, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (65.22) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhuri, A | 1 |
| Dandona, P | 1 |
| Manolopoulos, VG | 1 |
| Ragia, G | 1 |
| Tavridou, A | 1 |
| MUETING, VD | 1 |
| Panunti, B | 1 |
| Kunhiraman, B | 1 |
| Fonseca, V | 1 |
| Jawa, AA | 1 |
| Fonseca, VA | 1 |
| Yamada, Y | 1 |
| Marissal, JP | 1 |
| Sailly, JC | 1 |
| Crainich, D | 1 |
| Lebrun, T | 1 |
| Fisman, EZ | 1 |
| Motro, M | 1 |
| Tenenbaum, A | 1 |
| Floriani, M | 1 |
| Spadoni, M | 1 |
| Melander, A | 1 |
| Rull, JA | 1 |
| Dies, H | 1 |
| Schulte, J | 1 |
| Gomez-Perez, FJ | 1 |
| Sanchez-Gochicoa, J | 1 |
| Figueroa, J | 1 |
| Lozano-Castañeda, O | 1 |
| Sauer, H | 1 |
| Schneider, B | 1 |
| Huidobro, F | 1 |
| Videla, C | 1 |
| Hernández, G | 1 |
| Torres, H | 1 |
| Jimenez, R | 1 |
| Pérez, H | 1 |
| Díaz, RA | 1 |
| Raptis, S | 1 |
| Kenworthy, CW | 1 |
| Tikholov, K | 1 |
| Panzram, G | 1 |
| Delacrétaz, J | 1 |
| Baranov, VG | 1 |
| Orkodashvili, LSh | 1 |
| Mehnert, H | 1 |
| Levine, R | 1 |
| Lestradet, H | 1 |
| Ziegelasch, HJ | 1 |
11 reviews available for biguanides and Diabetic Angiopathies
| Article | Year |
|---|---|
Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.
Topics: Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Pe | 2011 |
Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.
Topics: Administration, Oral; Animals; Biguanides; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 2 | 2011 |
The impact of antidiabetic therapies on cardiovascular disease.
Topics: Biguanides; Diabetic Angiopathies; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazolidine | 2005 |
Role of insulin secretagogues and insulin sensitizing agents in the prevention of cardiovascular disease in patients who have diabetes.
Topics: Angioplasty, Balloon, Coronary; Animals; Biguanides; Blood Pressure; Chromans; Diabetic Angiopathies | 2005 |
[Glycemic control and diabetic complications].
Topics: Biguanides; Biomarkers; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus, Type 1; | 2005 |
Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
Topics: Benzamides; Biguanides; Coronary Disease; Diabetic Angiopathies; Drug Therapy, Combination; Humans; | 2008 |
Oral antidiabetic drugs: an overview.
Topics: Biguanides; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glucose Int | 1996 |
[What is achieved by the therapy with oral antidiabetics?].
Topics: Administration, Oral; Adult; Biguanides; Chlorpropamide; Diabetes Mellitus; Diabetic Angiopathies; D | 1976 |
[Skin and diabetes].
Topics: Biguanides; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Foot Diseases; Hemochro | 1973 |
[Initial phases of diabetes mellitus].
Topics: Biguanides; Blood Glucose; Cortisone; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathi | 1973 |
New horizons in our knowledge of diabetes mellitus.
Topics: Animals; Biguanides; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Glucagon; Glu | 1971 |
12 other studies available for biguanides and Diabetic Angiopathies
| Article | Year |
|---|---|
[STUDIES ON THE EFFECT OF A BIGUANIDE ON THE PROTEIN METABOLISM AND THE DETOXICATION ACTIVITY OF THE LIVER IN DIABETES MELLITUS].
Topics: Biguanides; Blood Protein Electrophoresis; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retino | 1964 |
[Assessment of the budgetary impact of treatment guidelines in type II diabetes mellitus in France].
Topics: Adolescent; Adult; Aged; Aspirin; Biguanides; Cerebrovascular Disorders; Coronary Disease; Cost-Bene | 2005 |
[Evaluation of HDL cholesterol in diabetes mellitus in relation to various types of therapy].
Topics: Administration, Oral; Aged; Arteriosclerosis; Biguanides; Blood Glucose; Cholesterol; Cholesterol, H | 1984 |
Long term treatment of asymptomatic diabetes.
Topics: Adult; Aged; Biguanides; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Female; Glu | 1979 |
[Lactic acidosis in diabetic patients associated with buformin].
Topics: Acidosis, Lactic; Aged; Bicarbonates; Biguanides; Buformin; Diabetes Mellitus; Diabetic Angiopathies | 1989 |
[Oral antidiabetic agents including glucosidase inhibitors].
Topics: Administration, Oral; Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; G | 1987 |
Letter: Coronary care for myocardial infarction in diabetics.
Topics: Biguanides; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diet Therapy; Humans; | 1974 |
[Treatment of patients with diabetes and diabetic angiopathies of the lower extremities with butylbiguanide (Silubin retard)].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biguanides; Diabetes Mellitus; Diabetic Angiopathies | 1974 |
[Possibilities and limits of primary prevention in diabetes mellitus].
Topics: Biguanides; Body Weight; Diabetes Mellitus; Diabetic Angiopathies; Dietary Carbohydrates; Female; Hu | 1974 |
[Differential therapy using oral antidiabetics].
Topics: Administration, Oral; Biguanides; Blood Glucose; Chemical Phenomena; Chemistry; Diabetes Mellitus; D | 1971 |
[Is there only one type of diabetes?].
Topics: Arteriosclerosis; Biguanides; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Ketoacidosis; Gluco | 1966 |
[Extreme hypoglycemia during combined tolbutamide, n-1-butylbiguanide hydrochloride and chloramphenicol therapy].
Topics: Age Factors; Aged; Biguanides; Chloramphenicol; Diabetes Mellitus; Diabetic Angiopathies; Diabetic N | 1972 |